Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

WatersCorp-GTxResolve

More Like This

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

PR Newswire associated0

Waters Announces Seamless HPLC/UPLC Data Bridge for Light Scattering, Integrating Essential Instruments for Large Molecule Characterization

PR Newswire associated0

Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer

PR Newswire associated0

Phenomenex Introduces Biozen dSEC-7, A New Way to Study AAVs with Unprecedented Speed and Efficiency

PR Newswire associated0

Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits

PR Newswire associated0

Waters Streamlines and Expedites PFAS Testing with Innovative Oasis Dual-Phase Cartridges

PR Newswire associated0

Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification

PR Newswire associated0

Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors